Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Amanda Grimes, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S of Alabama
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Benioff Children'S Hospital
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- Alfac Cancer and Blood Disorder Center: Scottish Rite
Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Riley Hospital for Children-Indiana University
Indianapolis, Indiana, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Randall Children'S Hospital
Portland, Oregon, United States
- the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Hasbro Children'S Hospital
Providence, Rhode Island, United States
- St. Jude Children'S Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 May 2019
- Primary completion
- 17 Apr 2024
- Completion
- 26 Feb 2025
- Last update posted
- 29 Jul 2025
- Registered enrollment
- 122
- Registry id
- NCT03939637
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.